HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALEBUND-B

24.980

+0.2801.13%

Volume:459.73K

Turnover:11.54M

Market Cap:8.69B

PE:-8.13

High:25.780

Open:24.960

Low:24.560

Close:24.700

52wk High:46.820

52wk Low:22.480

Shares:348.00M

HK Float Shares:236.00M

Volume Ratio:1.09

T/O Rate:0.19%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-3.071

ROE:--

ROA:-33.01%

PB:5.28

PE(LYR):-8.13

PS:60.63

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Alebund Posts 1H26 Revenue Surge on Licensing Deal; AP301 China NDA Accepted

Bulletin Express

Shares of ALEBUND-B Surge Over 17% in Afternoon Trading on US FDA Approval for IgA Nephropathy Drug Candidate

Alebund Pharmaceuticals (Jiangsu) Says IND Application for AP308 Cleared by U.S. FDA

ALEBUND-B Wins US FDA Nod to Start Trial of Novel IgA Nephropathy Drug AP308

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/09637"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09637","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09637\",,,,,undefined,":{"symbol":"09637","market":"HK","secType":"STK","nameCN":"ALEBUND-B","latestPrice":24.98,"timestamp":1790755706225,"preClose":24.7,"halted":0,"volume":459734,"delay":0,"changeRate":0.011336032388664014,"floatShares":236000000,"shares":348000000,"eps":-3.071284,"marketStatus":"Closed National Day","change":0.28,"latestTime":"09-30 16:08:26","open":24.96,"high":25.78,"low":24.56,"amount":11544552,"amplitude":0.049393,"askPrice":25.28,"askSize":3300,"bidPrice":24.98,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-2.326,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":7,"adr":0,"listingDate":1782662400000,"exchange":"SEHK","adjPreClose":24.7,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":1.0944484120534366,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09637\",,,,,undefined,":{"symbol":"09637","floatShares":236000000,"roa":"-33.01%","roe":"--","lyrEps":-3.071284,"volumeRatio":1.0944484120534366,"shares":348000000,"dividePrice":0,"high":25.78,"amplitude":0.049393,"preClose":24.7,"low":24.56,"week52Low":22.48,"pbRate":"5.28","psRate":"60.63","week52High":46.82,"institutionHeld":0,"latestPrice":24.98,"committee":-0.941176,"eps":-3.071284,"divideRate":0,"volume":459734,"delay":0,"ttmEps":-2.326,"open":24.96,"prevYearClose":22.6,"prevWeekClose":24.78,"prevMonthClose":24.98,"prevQuarterClose":24.98,"fiveDayClose":25.7,"twentyDayClose":28.9,"sixtyDayClose":32.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09637\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"09637","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09637\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09637\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":3,"updateTime":1787846400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09637\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09637","date":"2026-09-30","current":-10.739467,"percent":0.818182,"low":-18.066068,"twenty":-12.900389,"median":-11.399787,"eighty":-10.36452,"high":-8.42626,"avg":-11.62669,"sd":1.701453,"marketCap":8489508730},"quantilePoints":[{"date":"2026-06-26","current":-8.87585,"twenty":-8.87585,"median":-8.87585,"eighty":-8.87585,"marketCap":7680660420},{"date":"2026-07-03","current":-11.883178,"twenty":-18.03155,"median":-11.883178,"eighty":-9.78101,"marketCap":10290725554},{"date":"2026-07-10","current":-12.164969,"twenty":-13.966639,"median":-11.847257,"eighty":-11.12129,"marketCap":10521825071},{"date":"2026-07-17","current":-10.947234,"twenty":-12.322489,"median":-11.455859,"eighty":-10.783874,"marketCap":9502268378},{"date":"2026-07-24","current":-11.320561,"twenty":-11.939536,"median":-11.377389,"eighty":-10.939493,"marketCap":9828526520},{"date":"2026-07-31","current":-10.642718,"twenty":-11.840073,"median":-11.194259,"eighty":-10.78337,"marketCap":9257574772},{"date":"2026-08-07","current":-12.743391,"twenty":-12.396338,"median":-11.399787,"eighty":-10.889159,"marketCap":11106370909},{"date":"2026-08-14","current":-13.03884,"twenty":-12.987078,"median":-11.462395,"eighty":-10.903987,"marketCap":11378252693},{"date":"2026-08-21","current":-12.870195,"twenty":-13.077865,"median":-11.725167,"eighty":-10.931752,"marketCap":11255905890},{"date":"2026-08-28","current":-12.144658,"twenty":-13.077865,"median":-11.990608,"eighty":-10.959851,"marketCap":10623780741},{"date":"2026-09-04","current":-11.919154,"twenty":-12.988947,"median":-11.883178,"eighty":-10.931752,"marketCap":9787744252},{"date":"2026-09-11","current":-9.927508,"twenty":-12.953815,"median":-11.760082,"eighty":-10.889159,"marketCap":8163250588},{"date":"2026-09-18","current":-10.492422,"twenty":-12.949729,"median":-11.507967,"eighty":-10.606061,"marketCap":8639043712},{"date":"2026-09-25","current":-10.247785,"twenty":-12.923897,"median":-11.432455,"eighty":-10.595802,"marketCap":8421538284},{"date":"2026-09-30","current":-10.311257,"twenty":-12.900389,"median":-11.399787,"eighty":-10.36452,"marketCap":8489508730}],"updateTime":1790814725720},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09637\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1165350533","title":"Alebund Posts 1H26 Revenue Surge on Licensing Deal; AP301 China NDA Accepted","url":"https://stock-news.laohu8.com/highlight/detail?id=1165350533","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165350533?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:41","pubTimestamp":1789648881,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (Alebund) released its 2026 interim results, reporting a strong top-line lift driven by a one-off licensing transaction and steady growth from its commercialised anaemia...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alebund Posts 1H26 Revenue Surge on Licensing Deal; AP301 China NDA Accepted","news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151094926","title":"Shares of ALEBUND-B Surge Over 17% in Afternoon Trading on US FDA Approval for IgA Nephropathy Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1151094926","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151094926?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:58","pubTimestamp":1789451896,"startTime":"0","endTime":"0","summary":"Shares of ALEBUND-B (09637) rallied sharply in the afternoon, climbing more than 17% at one point. At the time of writing, the stock was up 12.96% to HK$25.98, with turnover reaching HK$36.28...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","BK4588","BK1515","09637","159938","BK4585","BK1191","BK1574","09939","BK1161","LABU","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665431379","title":"Alebund Pharmaceuticals (Jiangsu) Says IND Application for AP308 Cleared by U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2665431379","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665431379?lang=en_us&edition=fundamental","pubTime":"2026-09-08 23:31","pubTimestamp":1788881494,"startTime":"0","endTime":"0","summary":"Sept 8 (Reuters) - Alebund Pharmaceuticals (Jiangsu) Ltd <9637.HK>::*INVESTIGATIONAL NEW DRUG APPLICATION FOR AP308 FOR TREATMENT OF IGA NEPHROPATHY CLEARED BY U.S. FDA*Further company coverage: 9637.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nRSDYgyKG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141807270","title":"ALEBUND-B Wins US FDA Nod to Start Trial of Novel IgA Nephropathy Drug AP308","url":"https://stock-news.laohu8.com/highlight/detail?id=1141807270","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141807270?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:06","pubTimestamp":1788869176,"startTime":"0","endTime":"0","summary":"ALEBUND-B (09637) has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for AP308, a first-in-class engineered recombinant IgA...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","IBBJ","159938","PSYK","159151","09637","BMED","MDTX","BK1515","BK1191","IBBQ","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":18,"pageCount":1,"totalSize":69,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/09637\",params:#limit:6,delay:false,,,undefined,":[]}}